Equibles does not estimate personal net worth.
Get an email with a short summary when PROCEPT BioRobotics Corp publishes a filing, an earnings call transcript or a press release.
Get PRCT alertsKevin Waters is recorded as CFO at PROCEPT BioRobotics Corp (PRCT). The newest filing on record that lists Kevin Waters as CFO at PROCEPT BioRobotics Corp (PRCT) is dated April 22, 2026. The proxy statement of PROCEPT BioRobotics Corp reports total compensation of $2,750,253 for Kevin Waters in fiscal 2025, including a base salary of $502,250. Disclosed compensation is on record for 6 fiscal years. Kevin Waters has spoken on 20 earnings calls and 2 other investor events across 1 company, most recently for PROCEPT BioRobotics Corp on September 15, 2026. PROCEPT BioRobotics Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at PROCEPT BioRobotics Corp includes Larry L. Wood (CEO and Board Member), Larry Wood (CEO), Reza Zadno (CEO) and 7 others.
“This really was a build year for the company. We had to get through the field, Salesforce reorganization. We had to fully staff the launch team. We became fully enrolled in our Water Fork Cancer Study.”
“Total revenue for the second quarter of 2026 with $94.5 million representing 19% year-over-year growth. U.S. revenue totaled $83.4 million, an increase of 20% compared to the second quarter of 2025.”
“I mean, Larry and I both said it multiple times on the call. We feel great about pricing, but there's really no need to get out over our skis. Let's get another quarter under our belt, and then we'll more formally update those metrics.”
“Over the past six months, we have taken decisive actions to reset the organization. We have sharpened our focus on operational excellence, accountability, and commercial discipline.”
“Total revenue for the fourth quarter of 2025 was $76.4 million, representing 12% year-over-year U.S. revenue for the quarter was $66.6 million, reflecting 10% growth compared to the prior year period.”
Start not stated–present
Last confirmed April 22, 2026
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | PROCEPT BioRobotics Corp (PRCT) | EVP, Chief Financial Officer | $502,250 | $2,750,253 |
| 2024 | PROCEPT BioRobotics Corp (PRCT) | EVP, Chief Financial Officer | $482,500 | $2,187,988 |
| 2023 | PROCEPT BioRobotics Corp (PRCT) | EVP, Chief Financial Officer | $448,750 | $2,665,306 |
| 2022 | PROCEPT BioRobotics Corp (PRCT) | EVP, Chief Financial Officer | $415,000 | $1,322,305 |
| 2021 | PROCEPT BioRobotics Corp (PRCT) | EVP, Chief Financial Officer | $388,130 | $852,551 |
| 2020 | PROCEPT BioRobotics Corp (PRCT) | EVP, Chief Financial Officer | $388,130 | $735,008 |
